Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM Study (2024)
Attributed to:
MICA: Korea-UK PRISM consortium: Establishing Precision Medicine in severe asthma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00408-024-00670-w
PubMed Identifier: 38252134
Publication URI: http://europepmc.org/abstract/MED/38252134
Type: Journal Article/Review
Parent Publication: Lung
ISSN: 0341-2040